Remepy raises $136.0M (United States, Aug 2026)

$136.0M
$136M

Find the investors funding Health rounds

326,000+ verified VCs, angels and family offices — direct emails, check sizes and stage filters.

Find your investors →
Generated social card
Remepy social card
Headline

Remepy raises $136M for Parkinson's treatment — plus 5 more NYC VC deals to know - The Business Journals

About

Remepy is focused on developing innovative treatments for Parkinson's disease. The company aims to improve the quality of life for patients through its advanced therapeutic solutions. This funding round will help accelerate their research and development efforts.

Article summary

Remepy raises $136M for Parkinson's treatment — plus 5 more NYC VC deals to know  The Business Journals

Investors
Related rounds
Sep 03, 2026Catch$5.0MSeedUnited States
Sep 03, 2026Plenti$3.0MUnited States
Sep 02, 2026TabaPay$155.0MUnited States
Sep 02, 2026Lyte$165.0MSeries CUnited States

20,207 investors back startups in United States

You just read who funded Remepy. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.

Free account: 5 investor contact unlocks a month, no card required.

About the investors in United States